ABVX
Abivax SAHealthcare$118.37
▲ Bullish
Mkt Cap: $9.38B|Float: 64.1M|SI: 5.2%|DTC: 3.6
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
64.8%
52W Range
$5-$149
ATR(14)
$6.49
Exp. Move
±2.0%
P/C Ratio
0.50
Earnings
-
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Moderate
Low Put/Call
ABVX Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $2.2M
- Max Pain
- $115.00
- Expected Move
- ±2.0%
- Put/Call OI
- 0.50
- Net Premium
- $4.6M
- Spot Price
- $118.37
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-02 | 0 | ±$2.38 | ±2.0% | $116.00 | $120.75 |
| 2026-04-10 | 8 | ±$10.25 | ±8.7% | $108.12 | $128.62 |
| 2026-04-17 | 15 | ±$7.15 | ±6.0% | $111.22 | $125.52 |
| 2026-04-24 | 22 | ±$9.15 | ±7.7% | $109.22 | $127.52 |
| 2026-05-01 | 29 | ±$20.35 | ±17.2% | $98.02 | $138.72 |
| 2026-05-15 | 43 | ±$25.10 | ±21.2% | $93.27 | $143.47 |
Explore ABVX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.